TD Cowen Issues Pessimistic Forecast for Enovix (NASDAQ:ENVX) Stock Price

Enovix (NASDAQ:ENVX) had its price objective cut by stock analysts at TD Cowen from $15.00 to $7.50 in a research report issued to clients and investors on Thursday. The brokerage currently has a “hold” rating on the stock. TD Cowen’s price target indicates a potential upside of 21.95% from the stock’s previous close.

ENVX has been the topic of several other reports. Oppenheimer set a $24.00 target price on shares of Enovix in a report on Thursday, November 6th. JPMorgan Chase & Co. dropped their price objective on shares of Enovix from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, November 12th. Northland Securities set a $16.00 price objective on shares of Enovix in a research report on Monday, November 17th. Cantor Fitzgerald lowered their target price on Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, November 6th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Enovix in a research note on Monday, December 29th. Five investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Enovix presently has an average rating of “Hold” and an average price target of $16.75.

Enovix Trading Up 0.7%

NASDAQ ENVX opened at $6.15 on Thursday. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47. The stock’s 50-day moving average is $7.19 and its 200-day moving average is $8.96. Enovix has a one year low of $5.27 and a one year high of $16.49. The firm has a market cap of $1.33 billion, a P/E ratio of -7.59 and a beta of 2.13.

Institutional Trading of Enovix

A number of large investors have recently added to or reduced their stakes in ENVX. Vanguard Group Inc. boosted its holdings in shares of Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock worth $129,831,000 after buying an additional 1,747,145 shares during the period. Electron Capital Partners LLC raised its holdings in Enovix by 13.8% in the 3rd quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after acquiring an additional 972,103 shares during the period. Geode Capital Management LLC lifted its position in Enovix by 6.1% during the fourth quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock worth $32,268,000 after acquiring an additional 253,906 shares during the last quarter. State Street Corp boosted its holdings in shares of Enovix by 2.0% during the fourth quarter. State Street Corp now owns 3,959,029 shares of the company’s stock worth $28,941,000 after acquiring an additional 77,079 shares during the period. Finally, Royal Bank of Canada boosted its holdings in shares of Enovix by 18.0% during the fourth quarter. Royal Bank of Canada now owns 2,525,268 shares of the company’s stock worth $18,461,000 after acquiring an additional 385,983 shares during the period. Institutional investors and hedge funds own 50.92% of the company’s stock.

More Enovix News

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Q4 revenue and EPS beat consensus — Enovix reported revenue of roughly $11.3M (≈+16% YoY) and an EPS loss smaller than expected (-$0.14 vs. consensus -$0.17), which shows improving top-line traction and a narrower-than-feared loss. Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates
• Positive Sentiment: Gross-profit and operating improvement — Gross profit rose sharply year-over-year and operating loss narrowed (~27% improvement), suggesting margins are beginning to recover as volumes grow. Enovix Corporation (ENVX) Stock Falls on Q4 2025 Earnings
• Neutral Sentiment: Management emphasizes manufacturing ramp and market expansion — The earnings call highlighted strategic market expansion and a continued manufacturing scale-up that could boost future revenue but carries execution risk and timing uncertainty. Enovix Corp (ENVX) Q4 2025 Earnings Call Highlights
• Neutral Sentiment: EPS guidance slightly better than Street — Q1 EPS guidance of -$0.18 to -$0.14 compares favorably to consensus (-$0.19), which limits downside on near-term profitability expectations. Enovix Corporation (ENVX) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
• Negative Sentiment: Revenue guidance misses Street — Q1 revenue guide of $6.5M–$7.5M is below consensus (~$8.8M), which signals near-term growth softness and was a primary driver of the share decline. Enovix Q4 Release / Guidance (Press Release / Slides)
• Negative Sentiment: Liquidity and balance-sheet concerns — Cash fell to ~ $106M (year-over-year decline) and reported total liabilities rose materially, raising financing and cash‑burn concerns while the company scales manufacturing. Enovix Corporation (ENVX) Stock Falls on Q4 2025 Earnings (Quiver)
• Negative Sentiment: Insider sales and mixed institutional flows — Recent insider selling and large portfolio moves by institutions add pressure and may signal shorter-term skepticism among some holders. Enovix Corporation (ENVX) Stock Falls on Q4 2025 Earnings (Quiver)

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.